Form 8-K - Current report:
SEC Accession No. 0000950170-24-122266
Filing Date
2024-11-06
Accepted
2024-11-06 16:05:09
Documents
13
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rvmd-20241106.htm   iXBRL 8-K 41444
2 EX-99.1 rvmd-ex99_1.htm EX-99.1 165217
3 GRAPHIC img162218922_0.jpg GRAPHIC 83232
  Complete submission text file 0000950170-24-122266.txt   476393

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rvmd-20241106.xsd EX-101.SCH 44644
15 EXTRACTED XBRL INSTANCE DOCUMENT rvmd-20241106_htm.xml XML 6270
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 241430855
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)